Cycclone 

$0.049000
0
+$0.01+19.51% Wednesday 16:56

Statistics

Day High
0.041
Day Low
0.041
52W High
0.095
52W Low
0.0065
Volume
11,811
Avg. Volume
9,058
Mkt Cap
2.01M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jan 6
$5.52
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Financials

-Profit Margin
Profitable
2022
2023
2024
0Revenue
1.57MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zai Lab Limited
ZLAB
Mkt Cap2.31B
Zai Lab Limited is involved in discovering, developing, and commercializing a broad range of healthcare and pharmaceutical products, overlapping with CDBT's market in biotechnological healthcare solutions.
Sinovac Biotech
SVA
Mkt Cap642.44M
Sinovac Biotech Ltd. specializes in the research, development, manufacturing, and commercialization of vaccines, competing in the biotech sector focused on healthcare and medical treatments.
Wuxi AppTec.
WUXAY
Mkt Cap60.27B
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech, and medical device industries to advance discoveries and deliver groundbreaking treatments, directly competing with CDBT's services.
Can-Fite Biopharma
CANF
Mkt Cap6.96M
Can-Fite BioPharma Ltd. is a biotechnology company developing drugs with an emphasis on cancer, making it a competitor in the biotech industry focused on innovative treatments.
Gilead Sciences
GILD
Mkt Cap161.19B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need, competing in the biotech and healthcare sector.
AMGEN
AMGN
Mkt Cap196.12B
Amgen Inc. is one of the world's leading biotechnology companies, focusing on areas such as cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation, competing across several of CDBT's operational areas.
Pfizer
PFE
Mkt Cap137.76B
Pfizer Inc. is a global pharmaceutical corporation which develops and produces medicines and vaccines for a wide range of medical disciplines, including those covered by CDBT's biotechnological research and development.
Moderna
MRNA
Mkt Cap27.09B
Moderna, Inc. focuses on mRNA-based therapeutics and vaccines, competing in the innovative biotech sector where CDBT also aims to make its mark with biotechnological advancements and healthcare solutions.

About

Cycclone Inc., operating with its subsidiaries, specializes in the development, promotion, and distribution of bacteria-derived products. These offerings primarily function as beneficial additives for both agricultural crops and animal feed within the People's Republic of China. The company's product line includes various biological bacterium blends, notably those based on Artificial Microorganisms (AM) and High-efficiency Microorganisms (HM). For crop cultivation, these AM/HM blends – exemplified by Bulgaria lactobacillus, beer microzyme, and dark red spirilla – are designed to boost beneficial microbial populations in soil, suppress harmful fungi and putrefactive bacteria, enhance nutrient absorption, and ultimately help mitigate diseases in crops and livestock. In the livestock sector, AM/HM-based feed additives serve to tenderize feed, inhibit the growth of pathogenic bacteria, and provide crucial nutrients such as organic acids, vitamins, enzymes, antibiotics, mycelium protein, and other growth stimulants, thereby ensuring a balanced nutritional intake. Furthermore, Cycclone offers FGW bacterial preservatives, utilized for preserving animal specimens in scientific research and extending the freshness of agricultural produce. It also supplies bacteria-based fertilizers for foliar application on fruits and vegetables. Beyond its biotechnology operations, the company holds investments in residential and commercial real estate. Founded in 2004 as China Dasheng Biotechnology Co., the company officially adopted the name Cycclone Inc. in May 2025 and is headquartered in Lanzhou, China.
Show more...
CEO
Mr. Jinjun Qi
Employees
689
Country
United States
ISIN
US23255X1019

Listings

0 Comments

Share your thoughts

FAQ

What is Cycclone stock price today?
The current price of CYCL is $0.05 USD — it has increased by +19.51% in the past 24 hours. Watch Cycclone stock price performance more closely on the chart.
What is Cycclone stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Cycclone stocks are traded under the ticker CYCL.
Is Cycclone stock price growing?
CYCL stock has fallen by -0% compared to the previous week, the month change is a -18.33% fall, over the last year Cycclone has showed a +22.5% increase.
What is Cycclone market cap?
Today Cycclone has the market capitalization of 2.01M
What is Cycclone revenue for the last year?
Cycclone revenue for the last year amounts to 0 USD.
What is Cycclone net income for the last year?
CYCL net income for the last year is 1.57M USD.
Does Cycclone pay dividends?
Yes, CYCL dividends are paid en. The last dividend per share was 5.52 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Cycclone have?
As of July 15, 2026, the company has 689 employees.
In which sector is Cycclone located?
Cycclone operates in the Other sector.
When did Cycclone complete a stock split?
The last stock split for Cycclone was on January 21, 2000 with a ratio of 3:1.
Where is Cycclone headquartered?
Cycclone is headquartered in Lanzhou, United States.